Evidence map›Paper›PMID 17196195›Full record

ArticleExperimental and molecular pathology2007

Mapping of an origin of DNA replication in the promoter of fragile X gene FMR1.

Bruna P Brylawski, Paul D Chastain, Stephanie M Cohen, Marila Cordeiro-Stone, David G Kaufman

Open access · greenAbstract read
In one paragraph

Article in Experimental and molecular pathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Nucleosomal occupancy and CGG repeat expansion: a comparative analysis of triplet repeat region from mouse and human fragile X mental retardation gene 1.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2011
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bruna P BrylawskiDepartment of Pathology and Laboratory Medicine, C.B. #7525, University of North Carolina, Chapel Hill, NC 27599-7525, USA. bruna_brylawski@pathology.unc.edu
Paul D Chastain
Stephanie M Cohen
Marila Cordeiro-Stone
David G Kaufman
University of North Carolina at Chapel Hill · US

Funding

CANCER SUSCEPTIBILITY AND S PHASE INITIATION SITESR01CA084493 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAUFMAN, DAVID G. · 2000 to 2009
$2.5M
NCI NIH HHS CA084493NCI NIH HHS R01 CA084493
6 · The paper itself

Abstract

An origin of bidirectional DNA replication was mapped to the promoter of the FMR1 gene in human chromosome Xq27.3, which has been linked to the fragile X syndrome. This origin is adjacent to a CpG island and overlaps the site of expansion of the triplet repeat (CGG) at the fragile X instability site, FRAXA. The promoter region of FMR2 in the FRAXE site (approximately 600 kb away, in chromosome band Xq28) also includes an origin of replication, as previously described [Chastain II, P.D., Cohen, S.M., Brylawski, B.P., Cordeiro-Stone, M., Kaufman, D.G., 2006. A late origin of DNA replication in the trinucleotide repeat region of the human FMR2 gene. Cell Cycle 5, 869-872]. FMR1 transcripts were detected in foreskin and male fetal lung fibroblasts, while FMR2 transcripts were not. However, both FMR1 and FMR2 were found to replicate late in S phase (approximately 6 h into the S phase of normal human fibroblasts). The position of the origin of replication relative to the CGG repeat, and perhaps the late replication of these genes, might be important factors in the susceptibility to triplet repeat amplification at the FRAXA and FRAXE sites.

Indexed as

DNA ReplicationPromoter Regions, GeneticReplication OriginCell LineChromosome FragilityChromosomes, Human, XCpG IslandsFetusFibroblastsFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHumansLungMaleNuclear ProteinsSkinAFF2 protein, humanFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Nuclear ProteinsTrans-Activators

Identifiers

PMID17196195
PMCPMC1934615
OpenAlexW2071939931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.